Skip to content
Relatix Bio

Relatix Bio

Radically different

  • Services
  • Knowledgebase
  • Partnerships
  • Our Approach
  • Contact
  • About
    • Vision
    • Our mission
    • Privacy Policy
    • FAQ
    • News
Posted on July 14, 2026 by admin

Pressure mounts from MPs on Palantir’s role in the NHS

Jon Hoeksma says the question is no longer about whether Palantir will have its FDP contract terminated but when and how it will be done.
CategoriesImported News TagsHealthcare provider, United Kingdom

Post navigation

Previous PostPrevious FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist
Next PostNext Cellares and Sonoma Biotherapeutics Agree to Automate Engineered Treg Cell Therapy Manufacturing

This is the footer

Privacy Policy Proudly powered by WordPress